+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Monkeypox (Mpox) Diagnosis Market Outlook 2026-2034: Market Size, Share and Growth Analysis

  • PDF Icon

    Report

  • 160 Pages
  • October 2026
  • Region: Global
  • OG Analysis
  • ID: 6243049
UP TO OFF until Jan 01st 2027
The Monkeypox (Mpox) Diagnosis Market is estimated at US$2.4 billion in 2026 and is projected to grow at a CAGR of 4.6% to reach US$3.4 billion by 2034.

Market Overview

The Monkeypox (Mpox) Diagnosis Market covers tests, laboratory reagents, sampling products, and diagnostic workflows used to identify mpox infection.

Sample handling and the intended testing workflow determine suitable products; turnaround time and laboratory capability affect service capacity.

Key Companies Analysed

  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • Bio-Rad Laboratories
  • Danaher
  • Abbott
  • BD
  • Siemens Healthineers
  • Seegene
  • Hologic
  • Laboratory Corporation of America
  • Quest Diagnostics
  • Sansure Biotech
  • CerTest Biotec
  • BioPerfectus
  • Aptitude Medical Systems
  • TIB Molbiol
  • Genes2Me
  • Luminex
  • SD Biosensor

Geographic Coverage

  • North America - Market data and outlook to 2034
    • United States
    • Canada
    • Mexico

  • Europe - Market data and outlook to 2034
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Switzerland
    • Poland
    • Sweden
    • Russia

  • Asia-Pacific - Market data and outlook to 2034
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Malaysia
    • Vietnam

  • Middle East and Africa - Market data and outlook to 2034
    • Saudi Arabia
    • South Africa
    • Iran
    • UAE
    • Egypt

  • South and Central America - Market data and outlook to 2034
    • Brazil
    • Argentina
    • Chile
    • Peru

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

  • Updated PDF report and an MS Excel workbook containing market tables and figures.
  • 7-day post-sale analyst support for clarifications and in-scope supplementary data.
  • Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.

Table of Contents

1. Contents and Report Guide
1.1. List of Tables
1.2. List of Figures
2. Global Monkeypox (Mpox) Diagnosis Market Overview
2.1. Monkeypox (Mpox) Diagnosis Market Scope and Definitions
2.2. Research Methodology and Forecast Assumptions
2.3. Value Chain and Relevant Adjacent Markets
3. Monkeypox (Mpox) Diagnosis Market Dynamics
3.1. Demand Drivers
3.2. Constraints and Adoption Barriers
3.3. Technology and Commercial Trends
3.4. Regulatory and Supply-Chain Considerations
4. Monkeypox (Mpox) Diagnosis Market Strategic Analysis
4.1. Competitive Structure
4.2. Pricing and Purchasing Factors
4.3. Customer Requirements and Opportunity Assessment
5. Global Monkeypox (Mpox) Diagnosis Market Size, Share and Forecast, 2025-2034
5.1. Revenue Outlook, 2025-2034 (US$ billion)
6. North America Monkeypox (Mpox) Diagnosis Market Outlook to 2034
6.1. North America Market Snapshot
6.2. North America Outlook By Country
6.2.1. United States
6.2.2. Canada
6.2.3. Mexico
7. Europe Monkeypox (Mpox) Diagnosis Market Outlook to 2034
7.1. Europe Market Snapshot
7.2. Europe Outlook By Country
7.2.1. Germany
7.2.2. United Kingdom
7.2.3. France
7.2.4. Italy
7.2.5. Spain
7.2.6. Netherlands
7.2.7. Switzerland
7.2.8. Poland
7.2.9. Sweden
7.2.10. Russia
8. Asia-Pacific Monkeypox (Mpox) Diagnosis Market Outlook to 2034
8.1. Asia-Pacific Market Snapshot
8.2. Asia-Pacific Outlook By Country
8.2.1. China
8.2.2. Japan
8.2.3. India
8.2.4. South Korea
8.2.5. Australia
8.2.6. Indonesia
8.2.7. Malaysia
8.2.8. Vietnam
9. Middle East and Africa Monkeypox (Mpox) Diagnosis Market Outlook to 2034
9.1. Middle East and Africa Market Snapshot
9.2. Middle East and Africa Outlook By Country
9.2.1. Saudi Arabia
9.2.2. South Africa
9.2.3. Iran
9.2.4. United Arab Emirates
9.2.5. Egypt
10. South and Central America Monkeypox (Mpox) Diagnosis Market Outlook to 2034
10.1. South and Central America Market Snapshot
10.2. South and Central America Outlook By Country
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Chile
10.2.4. Peru
11. Monkeypox (Mpox) Diagnosis Market Competitive Landscape
11.1. Market Participants and Strategic Positioning
11.2. Company Profiles: Product Portfolios, Positioning and Strategies
11.2.1. Roche
11.2.2. Thermo Fisher Scientific
11.2.3. QIAGEN
11.2.4. Bio-Rad Laboratories
11.2.5. Danaher
11.2.6. Abbott
11.2.7. BD
11.2.8. Siemens Healthineers
11.2.9. Seegene
11.2.10. Hologic
11.2.11. Laboratory Corporation of America
11.2.12. Quest Diagnostics
11.2.13. Sansure Biotech
11.2.14. CerTest Biotec
11.2.15. BioPerfectus
11.2.16. Aptitude Medical Systems
11.2.17. TIB Molbiol
11.2.18. Genes2Me
11.2.19. Luminex
11.2.20. SD Biosensor
12. Appendix
12.1. Definitions and Abbreviations
12.2. Data Sources and Methodology
12.3. Publisher Information

Companies Mentioned

  • Roche
  • Thermo Fisher Scientific
  • QIAGEN
  • Bio-Rad Laboratories
  • Danaher
  • Abbott
  • BD
  • Siemens Healthineers
  • Seegene
  • Hologic
  • Laboratory Corporation of America
  • Quest Diagnostics
  • Sansure Biotech
  • CerTest Biotec
  • BioPerfectus
  • Aptitude Medical Systems
  • TIB Molbiol
  • Genes2Me
  • Luminex
  • SD Biosensor

Table Information